Plastic surgery is never just a simple process that can be done at the drop of a hat. There are many things for patients and surgeons to consider when going over the various procedures that are available. Dr. Jennifer Walden is a leading expert in the field of plastic surgery is often sought after for her skill and advice. Going through the best available options with a licensed professional is a must for anyone seriously considering plastic surgery. Jennifer Walden has extensive experience in all forms of plastic surgery and is an advocate for good bedside manner and ensuring every client is content happy about their surgery.
Los Angeles and New York are two of the biggest hotspots for plastic surgery, but to get Jennifer Walden’s expertise, one will have to travel to her hometown in Austin, Texas. Jennifer worked in New York for many years but took a move back to her hometown to be with family.When it comes to getting such impactful decision done, finding the perfect doctor is a must. Dr. Jennifer Walden is one of the best picks available for many reasons. Today, Jennifer is recognized all over the country for her plastic surgery expertise and has extensive work experience to show off with many satisfied customers.
Jennifer’s portfolio showing off her work can be found on her website, which also details her qualifications and experience working as a surgeon around the United States. Jennifer has worked with various industry experts over the years as well, bolstering her own experience and techniques.Dr. Jennifer Walden has many years of experience in plastic surgery today and has no trouble performing any form of plastic surgery for her clients. Most clients already know what to expect when dealing with Jennifer Walden as her reputation is spot on, being dependable and kind to everyone she comes into contact with. As a highly qualified surgeon and a member of the ASAPS, Jennifer’s progress in her industry is amazing and she plans to continue to build her career and influence.
Mikhail Blagosklonny is a well-known scientist with his studies focusing mostly on cancer and aging. His research interests are centered about cancer and targeted cancer therapies that prevent damaging of normal cells. He has an M.D. in internal medicine and a Ph.D. in experimental medicine and cardiology on impactjournals.com. He earned them at the First Pavlov State Medical University. In 2002, he became the associate professor of medicine at the New York College. He served as a senior scientist at Ordway Research Institute. In 2009, he was appointed as a Professor of Oncology at Roswell Park Cancer Institute.
Dr. Mikhail Blagosklonny is an author to more than 270 articles and research publications with over 25,000 citations. He is the founding Editor and the Editor-in-Chief of Cell cycle and Oncotarget. He is an associate editor of Cancer Biology and Therapy, Cell Death and Differentiation, American Journal of Pathology, and PLOS ONE. Dr. Mikhail Blagosklonny is the founding member of 700forscience. It consists of experts who have specialized in creating grassroots support systems for biotechnology systems.
Dr. Mikhail Blagosklonny research work ranges from cellular and molecular biology to clinical investigations including signal transduction, cellular senescence, and anticancer therapeutics. He has come up with a hypothesis on the possible role of Target of Rapamycin signaling in cancer and aging. He proposes the use of the eponymous drug Rapamycin as a useful anti-aging pharmaceutical on imoactjournals.com. Dr. Blagosklonny is known to be a passionate advocate of Rapamycin in longevity studies. He suggests that Rapamycin may be an effective drug against atherosclerosis, osteoporosis, cancer, autoimmune diseases, diabetes, obesity, macular degeneration, Alzheimer’s diseases, hypertension, and hypercoagulation.
In his research on aging, he tries to find out if the continuous developmental program on gettingstronger.org in the body that causes diseases of aging can be pharmacologically switched off before becoming hyper-functional and damaging. He tries to identify a molecular target which causes cell senescence, organism aging, and diseases of aging. He is the writer of the hyperfunction theory of aging and anti-cancer approaches. They are commonly referred to as chemotherapeutic engineering and cell cyclotherapy.